Copyright
copy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2010; 16(36): 4515-4518
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4515
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4515
Table 1 Treatment recommendations for pancreatic neuroendocrine tumors with von Hippel-Lindau disease[12]
| Treatment recommendation | |
| Prognostic criteria | |
| Tumor size ≥ 3 cm | |
| Mutation in exon 3 | |
| Tumor doubling time ≤ 500 d | |
| None of the criteria | Followed by CT/MRI every 2-3 yr |
| 1 criterion | Followed by CT/MRI every 6-12 mo |
| 2 or 3 criteria | Consider surgical intervention |
- Citation: Tamura K, Nishimori I, Ito T, Yamasaki I, Igarashi H, Shuin T. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J Gastroenterol 2010; 16(36): 4515-4518
- URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4515.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4515